Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence

Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence

BackgroundExcessive consumption of opioids is associated with impaired metabolic function including increased body mass index (BMI). Opioid antagonist naltrexone (NTX) is an effective treatment for opioid use disorder (OUD) that has the potential to mitigate such metabolic disturbances. Understandin...

Full description

Bibliographic Details
Main Authors: Xinyi Li, Daniel D. Langleben, Kevin G. Lynch, Gene-Jack Wang, Igor Elman, Corinde E. Wiers, Zhenhao Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Psychiatry
Subjects:
opioid use disorder
medication-assisted treatment
body weight gain
addiction
food
obesity
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1247961/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1247961/full

Similar Items